Céline Colacios Viatgé

Title: Céline Colacios Viatgé: Innovator in Cancer Treatment

Introduction

Céline Colacios Viatgé is a prominent inventor based in Toulouse, France. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 4 patents, his work focuses on enhancing the effectiveness of immune checkpoint inhibitors.

Latest Patents

Céline's latest patents include methods and pharmaceutical compositions for the treatment of cancer. One of his inventions relates to a method for enhancing the potency of an immune checkpoint inhibitor administered to a subject as part of a treatment regimen for cancer. This method involves administering a pharmaceutically effective amount of a TNFα blocking agent in combination with the immune checkpoint inhibitor. Another patent focuses on methods for enhancing the potency of immune checkpoint inhibitors, specifically through the administration of a pharmaceutically effective amount of a SK1 inhibitor alongside the immune checkpoint inhibitor.

Career Highlights

Throughout his career, Céline has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Centre Hospitalier Universitaire de Toulouse. His research has been pivotal in advancing cancer treatment methodologies.

Collaborations

Céline has collaborated with notable professionals in his field, including Thierry Levade and Nicolas Meyer. Their combined expertise has contributed to the development of innovative solutions in cancer therapy.

Conclusion

Céline Colacios Viatgé stands out as a key figure in the realm of cancer treatment innovation. His patents and collaborations reflect his commitment to improving therapeutic strategies for patients.